The partnership between Merck and the venture firm, follows the pharmaceutical company partnering with venture firm Lumira and fund of funds Teralys Capital last month.
US-based pharmaceutical company Merck yesterday partnered with venture firm Flagship Ventures on a strategic collaboration.
The pair are partnering on early stage life science innovation, with Merck’s Research Ventures Fund investing in Flagship latest fund.
As part of the partnership Merck will provide Flagship with access to its insight into pharmaceutical development, commercialization and regulation, in return for "exposure" to Flagship’s investment and venture creation model.
Roger Pomerantz, senior vice president worldwide licensing and knowledge management at Merck, said:…
